|
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer Clinical Trials Facts presented on Clinical Trials Search isn't designed to be a substitute for proven healthcare advice, calls or treatment by using a genuine medical doctor. We aren't mDs. Always confer with your doctor on Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer Clinical research trials and Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer healthcare trials occur in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new does drugs. The role of the studies / undertakings is to solve specific human healthcare questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to find treatments for all kinds of conditions, including Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer. Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer Clinical Trials and other clinical trials allow for volunteers to access health treatment choices before they are available to the general public. Many times the test subjects get treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer clinical trial. Test subjects typically receive the most effective healthcare possible for their Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer condition. Risks are a reality, nonetheless, and could include extra or frequent dr. calls, health hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer  Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
For Condition: transitional care planning,Fatigue,Cancer,Depression,psychosocial effects and treatment,menopausal symptoms
Status: No longer recruiting
Sponsor(s): Fred Hutchinson Cancer Research Center , National Cancer Institute (NCI)
Synopsis: RATIONALE: Telephone counseling by trained counselors may enhance the well-being and quality of life of patients who have undergone stem cell transplantation for cancer. PURPOSE: Randomized clinical trial to compare the effectiveness of standard follow-up care with extended follow-up care in treating patients who have undergone stem cell transplantation for cancer.
Details: OBJECTIVES: - Compare the recovery course of patients with malignancies who undergo standard vs extended recovery preparation after hematopoietic stem cell transplantation. - Compare the efficacy of these recovery preparations in managing rehabilitation needs, including reduced stamina and cognitive limitations, of these patients. - Compare the ability of these recovery preparations to assist patients and caregivers in adjusting to unavoidable fluctuations in caregiver roles and emotions. - Compare the ability of these recovery preparations to assist female patients in managing menopausal symptoms and sexual function changes. OUTLINE: This is a randomized, multicenter study. Patients are stratified according to gender, type of transplantation (allogeneic vs autologous), ethnicity (Caucasian vs non-Caucasian), total body irradiation (yes vs no), and participating center. Patients are randomized to 1 of 2 supportive care arms. Patients complete 1 baseline assessment prior to transplant and a second assessment after the transplant, approximately 1 week before returning home. - Arm I (Standard Recovery Preparation): Patients and caregivers receive standard preparation prior to discharge, a booklet of stem cell transplant-related resources and contact information, and the National Cancer Institute-produced publication entitled "Facing Forward". - Arm II (Recovery Preparation Intervention): Patients and caregivers receive standard preparation and resource materials as in arm I. Women also receive 10 scheduled telephone appointment sessions, lasting 1 hour each, over the first year after returning home. Men receive 9 scheduled telephone appointment sessions in the same manner as the women. The first 5-6 sessions have a specific topic with a corresponding video. The last 4 calls are booster calls to answer questions, identify new problems, and provide support. Patients with acute problems or problems that cannot be handled through regular sessions are referred to the interdisciplinary recovery triage team. Problems addressed by this team include depression, agitation, cognitive change, fatigue, family disruptions, sexuality, and gynecologic or menopausal difficulties. Patients are followed at 1 and 2 years. PROJECTED ACCRUAL: A total of 412 patients and their caregivers (385 patients randomized) will be accrued for this study within 4 years.
Eligibility:
Study Type: Interventional, Treatment
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: DISEASE CHARACTERISTICS: - Diagnosis of a malignancy - Planned bone marrow, stem cell, or umbilical cord transplantation after a myeloablative conditioning regimen - Must have completed radiotherapy and conditioning chemotherapy - Must be first stem cell transplantation - Must recover sufficiently, physically and cognitively, to be ambulatory and able to live at home - Must be planning to live with primary caregiver for at least 3 months upon return home - No refractory breast cancer requiring treatment on a phase I protocol PATIENT CHARACTERISTICS: Age - 18 and over Performance status - Not specified Life expectancy - Not specified Hematopoietic - Not specified Hepatic - Not specified Renal - Not specified Other - Must be able to read, write, and communicate well by phone in English - Must not be deaf or blind - Must live in the United States - Must not be too ill or in too much pain - No major psychiatric disorders not in remission - No prisoners - No prior major alcohol or drug abuse - No major cognitive problems - No other concurrent confounding major illness PRIOR CONCURRENT THERAPY: Biologic therapy - See Disease Characteristics Chemotherapy - See Disease Characteristics Endocrine therapy - Not specified Radiotherapy - See Disease Characteristics Surgery - Not specified
Total Enrollment:
Location and Contact Information:
Overall Study Official:
KarenSyrjala, Study Chair, Fred Hutchinson Cancer Research Center
Stanford University Medical Center
Stanford, California, 94305-5623
United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, 48201-1379
United States
AMC Cancer Research Center
Denver, Colorado, 80214
United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109-1024
United States
Shands Hospital and Clinics, University of Florida
Gainesville, Florida, 32610-100277
United States
Huntsman Cancer Institute
Salt Lake City, Utah, 84132
United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48109-0914
United States
Rocky Mountain Cancer Centers
Denver, Colorado, 80218
United States
Comprehensive Cancer Center at Wake Forest University
Winston Salem, North Carolina, 27157-1082
United States
Additional Information:
Study ID Numbers: CDR0000258109; NCI-H02-0096,FHCRC-1430.00
Study Start Date:
Record last reviewed: March 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00049465
Other Depression Studies:
1. Improving Cancer Pain Management Using AHCPR Cancer Pain Guidelines
2. A Phase 1 Trial of ALIMTA (pemetrexed) in Patients With Locally Advanced or Metastatic Cancer
3. Evaluation and Natural History of Children with Cancer and AIDS
4. Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma
5. Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer or Other Solid Tumors
Related Studies:
Other Depression Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials
Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer
|
|
|
|
|
|
|
|
